Daniel O'Day — SPARQNOW

At-a-Glance

Chairman and Chief Executive Officer at Gilead Sciences since 2019.
Board Member at Georgetown University since 2023.
Board Member at PhRMA since 2019.
Previously spent over 32 years at Roche.
Holds a Master's degree in Business Administration and Management.
Holds a Bachelor's degree in Biology.

Biography

Daniel O'Day serves as the Chairman and Chief Executive Officer of Gilead Sciences, a role he has held since 2019. In this capacity, he works with Gilead employees globally to advance groundbreaking science and enhance access to medicine, with a stated commitment to delivering transformative therapies through innovation.

Prior to joining Gilead Sciences, O'Day spent over 32 years at Roche.